AstraZeneca victorious in patent battle July 3, 2008 Shares in AstraZeneca, the drugs giant, jumped nearly 5 per cent yesterday after it won a key patent battle in America over Seroquel, its anti-psychotic drug and second-best seller. The decision by a US court to award a summary judgment in AstraZeneca’s favour avoids the need for a full trial and means that generic copies [...]
Killing the cure October 28, 2005 Some say British drugs companies should be able to profit in order to reinvest in newer drugs for the greater good. Some say their profits come on the back of scientific fraud. It is perhaps one of the great puzzles of British business. As a nation we spend less on medicines than our European neighbours, [...]